HOME >> MEDICINE >> NEWS
International breast cancer prevention study launches in the United States and Canada

Boston-March 30, 2005 Today, a new clinical trial evaluating a novel approach to breast cancer prevention launched in the United States and Canada. Called the ExCel research study, this is the first North American clinical trial to evaluate the role of an aromatase inhibitor in the prevention of breast cancer.

Coordinated by the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG), the ExCel research study will examine the potential benefit of exemestane and its ability to prevent breast cancer in women who are at increased risk for the disease. Exemestane part of a class of drugs called aromatase inhibitors suppresses estrogen production, a key component in the development of some types of breast cancer. Exemestane could provide women with an alternative option to tamoxifen, the only drug FDA approved for prevention of breast cancer.

"Breast cancer is a major public health issue every 30 seconds somewhere in the world a woman is diagnosed with this disease," says Dr. Paul Goss, the ExCel research study chair.

"Thousands of women have already beat breast cancer thanks to recent research on aromatase inhibitors. As a result, we think this could be an effective approach to preventing it from developing in the first place."

The ExCel research study will follow more than 4,500 postmenopausal women from the U.S., Canada and Spain over a five year period. To be eligible, women must be 35 years of age or older and have an increased risk of developing breast cancer. Risk factors can include a woman's age, her family history of breast cancer, her age at first menstrual period and her age at first live birth.

Initial results of the trial could be available within four years and study investigators hope to see as much as a two-thirds reduction in the incidence of breast cancer among women in the treatment group.

Aromatase inhibitors are currently being used to treat breast cancer in wo
'"/>

Contact: Samantha Kaplan
samantha.kaplan@edelman.com
312-297-7439
Edelman Public Relations
30-Mar-2005


Page: 1 2 3 4

Related medicine news :

1. National Academies advisory: May 2 Symposium on International Science Policy
2. Awards & fellowships at the International & American Association for Dental Research General Session
3. Lectures, keynoters, symposia highlight International Dental Research meeting
4. Advances in Uterine Leiomyoma Research: 2nd NIH International Congress
5. International gathering of experts to share retinoblastoma breakthroughs
6. International trial of two microbicides begins
7. International gathering at UH examines top computer code
8. International trial finds benefits of breast MRI in women at high risk
9. International study provides culture-by-culture clues to family violence and abuse
10. St. Jude scientist wins International Society of Experimental Hematology award
11. International MRC trial finds a routine treatment for head injury may do more harm than good

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/19/2020)... Fla. (PRWEB) , ... February 19, 2020 , ... SEAL ... year as a result of healthcare-acquired infections (HAIs.) According to The Centers for Disease ... for is the large amount of screens that are now acting as an extension ...
(Date:2/16/2020)... ... 2020 , ... Accumen Inc., the leader in healthcare performance ... Joint Commission to provide a complimentary series of Patient Blood Management (PBM) Certification ... safety officers) within U.S. hospitals. , “Accumen’s mission is to help ...
(Date:2/15/2020)... SKOKIE, Ill. (PRWEB) , ... February 14, 2020 ... ... performance, color-coded cleaning products, partnered with Baptist Easley Hospital , a member ... ensuring safe patient environments. With PCPLUS, the world-class hospital was able to cut ...
(Date:2/15/2020)... VEGAS (PRWEB) , ... February 14, 2020 , ... It ... Isabella Martinez (Creator), started drawing these heart-shaped characters and knew she was on to ... mission to support children navigate through any life challenge including a health condition or ...
(Date:2/14/2020)... ... 14, 2020 , ... The Dr. Oz Show is an American daytime television ... and medical information. As an upcoming guest on the show, New York City ... in-depth medical knowledge. During the segment, Dr. Linkov, a leader and trusted authority on ...
Breaking Medicine News(10 mins):
(Date:2/20/2020)... ... ... Enquire, a leading provider of cloud CRM, marketing automation and sales contact ... a Silver Sponsor of Enquire Summit 2020, scheduled for April 20 - 22, 2020 ... a Silver Sponsor. This event truly empowers sales and marketing professionals in the senior ...
(Date:2/20/2020)... ... February 20, 2020 , ... CSG ... to perform Independent Verification and Validation (IV&V) services for the Massachusetts Executive ... Eligibility System (HIX/IES) project. , EOHHS, along with the Commonwealth Health Insurance ...
(Date:2/19/2020)... ... , ... Today, Georgetown Home Care (GHC) announces ... lowest in the company’s history. , Georgetown Home Care’s hospital readmission rate ... skilled nursing facility (SNF) rehospitalization rate was 0 percent in 2019. When compared ...
Breaking Medicine Technology:
Cached News: